Lege 2003, øyelege og PhD 2010, professor 2015
Interessefelt: regenerative medisin, stamcellebiologi, inkludert bruk av munnslimhinneceller for behandling av blindhet, tørre øyne og innovasjon
Summary
Awards/honors: 24 (6 related to innovation) |
Additional awards/honours based on co-author contributions: 10 |
Supervision of PhD-candidates as main or co-supervisor: 20 (13 current; 7 past) |
Supervision of medical research students (3-years research program): 16 (12 current; 3 past; main supervisor for 11; co-supervisor for 4) |
Supervision of dental research students (3-year research programme): (4 current, co-supervisor) |
Supervision of medical students (master`s thesis/3-months research projects): 13 (6 current; 7 past; 11 main supervisor; 2 co-supervisor) |
National and international invited talks: 93 |
Publications or submitted manuscripts in peer-reviewed journals: >110 (a total of 33 last authorships; 48 peer-reviewed papers since January 2016, the latest related to stem cells in Nature Communications (in press) |
Abstracts: 175 |
Patent applications: 6 |
Companies established: 6 |
Current positions related to research and/or innovation: 15 |
Current professorships (full): 4 |
External funding as project leader or project collaborator since 2004: $22 million. |
Main academic achievements: |
4 professorships; Harvard Medical School faculty member (since 2013); together with my research group, recipient of the largest innovation prize related to health care in Norway (Medinnova’s Innovation Award of $33,000 based on stem cell research); winner of the European Society of Ophthalmology Award for most promising Norwegian Young Clinician/Researcher; received the Oslo University Hospital Early Career Award for outstanding research ($20,000); received an EU grant in 2017 of $5 million (consortium member); received a Norwegian Research Council grant in 2017 of $1.3 million (principal investigator) |
Academic Background and Main Positions:
2018 - present | President, Oslo Society of Ophthalmology (established 1905), Oslo, Norway |
2018 - present | Professor in Innovation, Department of Research and Development, Oslo Metropolitan University, Oslo, Norway |
2018 - present | Head, Unit for research-based innovation, Division of Head, Neck and Reconstructive Surgery, Oslo University Hospital, Oslo, Norway |
2017 - present | Professor, Department of Clinical Medicine, Faculty of Medicine, University of Bergen, Bergen, Norway |
2017 - present | President, Oslo Society of Ophthalmology, Oslo, Norway |
2017 - present | Director of Innovation/Senior Consultant/Senior Scientist, Department of Ophthalmology, Stavanger University Hospital |
2017 - present | Director of Research/Director of Innovation/Senior Consultant, Department of Ophthalmology, Arendal Hospital |
2017 - present | Senior Scientist, Department of Maxillofacial Surgery, Oslo University Hospital, Norway |
2017 - present | Senior Consultant, Mobilize Strategy Consulting, Oslo, Norway |
2016 – present | Director of Innovation, Division of Head, Neck and Reconstructive Surgery, Oslo University Hospital, Norway |
2016 – present | Senior Scientist, Department of Plastic and Reconstructive Surgery, Oslo University Hospital, Norway |
2016 – present | Senior Consultant/Senior Scientist, Department of Ophthalmology, Oslo University Hospital, Norway |
2016 – present | Professor (since 2016) and Head of Electron Microscopy lab (since 2014), Department of Oral Biology, Faculty of Dentistry, University of Oslo, Norway |
2016 – present | Editor-in-Chief, Oftalmolog (Nordic journal of ophthalmology) |
2015 – present | Professor, Department of Optometry and Visual Science/National Centre for Optics, Vision and Eye Care, Faculty of Health Sciences,University College of Southeast Norway |
2015 – present | Director of Research/Senior Consultant, Department of Ophthalmology, Drammen Hospital, Drammen, Norway |
2015 – present | Director of Research, the Norwegian Dry Eye Clinic, Oslo/Fredrikstad/Tromsø, Norway |
2014 – present | Head of Unit of Regenerative Medicine, Department of Medical Biochemistry, Oslo University Norway Hospital |
2013– present | Adjunct Clinical Associate, Schepens Eye Research Institute/Massachusetts Eye and Ear, Department of Ophthalmology, Harvard Medical School, Boston, U.S (appointed Faculty Member in December 2013) |
2015 – 2017 | Vice President for the Norwegian Society of Ophthalmology |
2015 - 2016 | Director of Innovation, Oslo University Hospital, Norway (one-year engagement) |
2014 - 2015 | Associate Professor/Head of EM-lab, Department of Oral Biology, Faculty of Dentistry, University of Oslo, Norway |
2014 | Visiting Scientist, Schepens Eye Research Institute, Massachusetts Eye and Ear, Department of Ophthalmology, Harvard Medical School, Boston, U.S (two months) |
2013 - 2014 | Acting Group Leader at the Unit of Regenerative Medicine, Department of Medical Biochemistry, Oslo University Hospital |
2012 - 2013 | Fulbright Visiting Scholar at Schepens Eye Research Institute, Massachusetts Eye and Ear Infirmary, Department of Ophthalmology, Harvard Medical School, Boston, U.S. |
2012 - 2013 | Director of Research at the Dry Eye Clinic, Oslo, Norway |
2012 - 2013 | Chief Executive Officer for SynsLaser in Oslo and Tromsø, Norway |
2011 | Ophthalmologist (completed the five-year training program at the Department of Ophthalmology, Oslo University Hospital) |
2011 | Senior Research Fellow at Department of Medical Biochemistry, Oslo University Hospital |
2010 | Philosophia Doctor (PhD), "Novel technology in regenerative medicine: Eye bank storage of limbal explant cultures for transplantation" |
2010 | Chief Scientific Officer of Regena Medical AS, Norway |
2009 | Director of Research for Ophthalmology, Inven2, Oslo University Hospital |
2009 | Guest Scientist at Kyoto Prefectural University of Medicine, Japan |
2008 | Visiting Scientist at Schepens Eye Research Institute, Department of Ophthalmology, Harvard Medical School Boston, US |
2007 - 2011 | Resident in Ophthalmology (with a few short leaves of absence due to research or innovation projects, the longest being six months as a consequence of an invitation to Harvard Medical School in 2008) |
2005 - 2007 | Lecturer/PhD candidate |
2004 - 2005 | Resident in Ophthalmology |
2003 - 2004 | University Lecturer, Oslo University Hospital, Rikshospitalet/Oslo |
2001 | Doctor of Medicine (MD) (laudabilis), University of Oslo, Norway |
Supervisor Experiences (in total: 56 scientists):
Main supervisor: 9 PhD candidates (6 of whom have defended their theses: Jon Roger Eidet, Catherine Jackson, Rakibul Islam, Xiangjun Chen, and Aleksandar Stojanovic, Lara Pasovic. In addition, Øygunn Aass Utheim has submitted her thesis) |
Co-supervisor: 12 PhD candidates (one of whom has defended her thesis: Ida Fostad. In addition, Peder Aabel has submitted his thesis) |
Supervisor: 15 medical research students at the Faculty of Medicine, University of Oslo (1 year full-time and 2-year part-time research). The first student (Lara Pasovic) has 8 publications and 2 patent applications and defended her medical research thesis on November 25, 2015. Another two students, Marlen Parissi and Marit Lippestad, have defended their theses |
Supervisor: 4 research students at the Faculty of Dentistry, University of Oslo (1-year full-time and 2-year part-time research) |
Supervisor: 3 postdoctoral fellows |
Main supervisor: 12 medical students (3-month research program, University of Oslo). A digital publication at the University of Oslo is the aim of this research program. The studies performed by the students are formally listed as master’s theses by the University of Oslo. Seven students so far have completed the program |
Co-supervisor: 2 master’s students at the Faculty of Dentistry, University of Oslo; and Master’s Program in International Health Policy, University College in Oslo and Akershus |
Awards/Honours (24):
2017: Short Term Scientific Mission Scholarship, European Cooperation in Science and Technology under the Seventh Framework Programme (FP7), 2017. |
2017: Oslo University Hospital Early Career Award for Outstanding Research. Prize money NOK 150.000. Evaluation criteria: 1) Maximum 8 years of experience since completion of PhD and scientific track record showing great promise (any age); and 2) scientific excellence, i.e: peer review evaluation of scientific quality and impact. The international evaluation committee was led by Professor Sten Lindahl, Karolinska Institutet. Lindahl has previously served as chairman for the Nobel Prize Committee for Physiology or Medicine |
2015: Søren Holths Award (includes prize money) for best presentation skills evaluated over the past two years, Norwegian Society of Ophthalmology (first time the award was given since 2005) |
2016: Innovator of the Month, South-Eastern Norway Regional Health Authority, January 2016 |
2015: Outstanding Reviewer Award (Nanomedicine: Nanotechnology, Biology, and Medicine, Elsevier 5-year Impact Factor: 7.3) |
2015: Scholarship for the European Leadership Development Programme (2015-2017) |
2014: Travel Award by Oslo University Hospital to Harvard Medical School |
2014: Scholarship to attend a course, equivalent to 1/3 of a master`s degree, on innovation in collaboration with the Norwegian Business School; Berkley, University of California, CA; and Stanford University, CA (selected by the Norwegian Research Council based on an ongoing innovation project in competition with innovation projects from a variety of disciplines, including IT, agriculture, oil industry, and medicine). Three selected from Oslo University Hospital for the Scholarship, whereof two were from my research group. |
2014: Best Poster Award (2nd European Conference on Aniridia, Venice, Italy) |
2013: Alcon Research Prize in Ophthalmology |
2013: Travel Award by Oslo University Hospital to Harvard Medical School |
2013: Lecturer Travel Award (sponsored in part by the U.S. Department of State) |
2012: Fulbright Visiting Scholarship to Harvard University (14 months), sponsored in part by the U.S. Department of State |
2012: Most Promising Young Clinician/ Researcher Award resulting in the European Society of Ophthalmology (SOE) Lecturer Award, National Society of Ophthalmology, November 2012. |
2012: Travel Award by Oslo University Hospital to Harvard Medical School |
2010: DNB Innovation Prize (finalist in Oslo) |
2009: Director`s Award for Excellent Research, Oslo University Hospital, Ullevål |
2008: Best Poster Award, Nordic Congress of Ophthalmology |
2008: First prize winner of the Medinnova Innovation Competition, which is the largest innovation prize in health care in Norway (prize money NOK 250.000 - shared with members of the research group) |
2007: Second prize winner of the Medinnova Innovation Competition |
2001: The Voluntary International Medical Exam - first prize winner among University of Oslo students. The award and prize money were received at a ceremony at the University Aula in Oslo, Norway, November 21, 2001 |
1995: Best overall score of all time when graduating from high school. The score resulted in press release in some of the largest newspapers in Norway. The school was founded in 1951. |
1992: Best overall score of all time when graduating from junior high school. |
Awards/Honours Based on Co-Author Contribution (10)
Awards/Honours Based on Co-Author Contribution (10): |
2018: 14th International Sjogren’s Syndrome Symposium Travel Award (co-author contribution) |
2017: International Colour Vision Society Travel Award (co-author contribution) |
2017: Best paper at the Department of Medical Biochemistry, Oslo University Hospital (August to December, 2017), resulting in nomination to the twice yearly best paper contest at Oslo University Hospital. A maximum of 25 papers twice a year can be nominated from the entire hospital (last author contribution) |
2016: Best thesis (PMID: 28811665) at the Department of Oral biology, Faculty of Dentistry, from January 2014 to January 2016, resulting in the nomination for The Kings Gold Medal, University of Oslo, Norway. PhD candidate: Rakibul Islam; main supervisor Tor Paaske Utheim; title of thesis: Treatment of Limbal Stem Cell Deficiency: Cell-Based Regenerative Therapy and Storage System (main supervisor contribution) |
2016: Best paper (PMID: 26940175) at the Department of Medical Biochemistry, Oslo University Hospital (January to July, 2016), resulting in nominated to the best paper contest at Oslo University Hospital. A maximum of 25 papers twice a year can be nominated from the entire hospital (last author contribution) |
2015: EULAR Conference, Zürich, Switzerland: Poster Selected to “Guided Poster Tour” (co-author contribution) |
2014: ARVO International Travel Grant (last author contribution) |
2012: Best Paper Award, Socleta Italiana Cellule Staminali e Superficie Oculare, Rome, Italy based on the paper: Chen X, Stojanovic A, Stojanovic F, Raeder S, Eidet JR, Oritsland H, Utheim TP: Effect of limbal marking prior to laser ablation on the magnitude of cyclotorsional error. J Refract Surg. 2012 May;28(5) (last author contribution) |
2010: ARVO International Travel Grant (co-author contribution) |
2008: Director`s Award for Excellent Research, Oslo University Hospital (second-author contribution) |
Publicity Based on Innovation/Research From My Research Group: (Television: 3, Newspaper: 4, Webpages: Numerous):
Television: |
EuroNews, Science/Hi-Tec, week 38, 2007 (the main European news channel). |
NRK Dagsrevyen, August 16, 2007 (the main Norwegian news channel) |
Schrødingers Katt, September 2, 2010 (the main Norwegian science channel) |
Newspapers (a selection): |
Dagens næringsliv, August 11, 2017 |
Optikeren (nr 1. 2016) |
Klassekampen (February 26, 2016) |
Alt om syn (Norwegian journal about vision), October 28, 2011 and issue nr 4, 2015 |
Nationen (Norwegian newspaper), September 5, 2015 |
The Journal of the Norwegian Medical Association, August 12, 2010 |
Aftenposten (main Norwegian newspaper) November 22, 2007 |
Ullevål-Nytt (newspaper for Oslo University Hospital, Ullevål), December, 2007 |
Web Pages: |
tidsskriftet.no, forskning.no (x3), forskningsradet.no (x2), EuroNews.com (main page), nrk.no, helse-sorost.no, oslo-universitetssykehus.no, tannlegeforeningen.no, medinnova.no, blindeforbundet.no, abcnyheter.no, optikeren.no, dn.no, innovationmanagement.se, sciencedaily.com, ntbinfo.no, medicaldaily.com, healthcanal.com, odont.uio.no, uio.no (main page for 10 days), MedicalXpress.com, scifeeds.com, scincenordic.com, dental-tribune.com, etc |
Administrative Qualifications (19 Administrative Positions Since 2008):
2018- present | Professor, Oslo Metropolitan University, Oslo, Norway |
2018- present | President of the Oslo Society of Ophthalmology (established 1905), Oslo, Norway |
2018–present | Head, Unit for research-based innovation, Division of Head, Neck and Reconstructive Surgery, Oslo University Hospital, Oslo, Norway |
2017- present | Director of Innovation/Senior Consultant/Senior Scientist, Stavanger University Hospital, Stavanger, Norway |
2017 - present | Director of Research/Director of Innovation/Senior Consultant Department of Ophthalmology, Sørlandets Sykehus, Arendal, Norway |
2016 –present | Editor-in-Chief for Oftalmolog, a Nordic Journal of Ophthalmology |
2016 –present | Director of Innovation, Division of Head, Neck and Reconstructive Surgery, Oslo University Hospital, Norway |
2015 –present | Director of Research, Department of Ophthalmology, Drammen Hospital, Norway |
2015 –2017 | Vice President, The Norwegian Society of Ophthalmology, Oslo, Norway |
2015 - 2016 | Director of Innovation, Oslo University Hospital, Norway |
2013 - present | Acting Group Leader and later (2014) Group Leader of the Unit of Regenerative Medicine, Department of Medical Biochemistry, Oslo University Hospital |
2014 - present | Head of the electron microscopy laboratory, Institute of Oral Biology, Faculty of Dentistry, University of Oslo (since autumn 2015 shared position with Professor Linda Hildegard Bergersen) |
2014 - present | Head of the Scientific Committee of Aniridia Europe |
2011 - present | Head of the Scientific Committee of Aniridia Norway |
2012 - 2013 | Director of Research, the Dry Eye Clinic, Oslo and Tromsø, Norway |
2012 - 2013 | Chief Executive Officer of SynsLaser (private eye clinic with its own unit for research and development) in Oslo and Tromsø, Norway |
2010 | Chief Scientific Officer of Regena Medical AS, Norway |
2009 | Director of Research for Ophthalmology, Inven2, Oslo University Hospital |
2008 | Shared Project Leader (with Professor Darlene A. Dartt) on a project related to storage of cultured cells at Schepens Eye Research Institute, Massachusetts Eye and Ear, Department of Ophthalmology, Harvard Medical School, Boston, US |
Funding:
Total funding based on grant applications as either project leader or project collaborator over the past 10 years has increased steadily and now amounts to approximately $22 million, about half of which was secured over the past 3 years. The funding includes an EU grant (Horizon 2020) of $5 million (consortium member) and a Norwegian Research Council grant of $1.3 million (principal investigator) |
Teaching and Pedagogic Qualifications:
Co-authored a book with Sten Ræder, Utheim TP, and Utheim OA entitled: Ophthalmology – basal clinical examination (Unipub, Oslo, Norway, 2012, 133 pages), which has been distributed to thousands of medical students in Norway and abroad since 2008. The authors are in the final stages of writing a more comprehensive book on ophthalmology |
Teaching responsibilities in ophthalmology to more than 650 medical students since 2004. None of them failed their oral examination |
Establishment of Companies:
2017 - Velotrail (bike safety company) |
2016 - The Eye Health Clinic |
2016 - The Glaucoma Clinic |
2015 - Digital Ophthalmology |
2012 – The Norwegian Dry Eye Clinic |
2010 - Regena Medical (a biotech company) |
International collaboration:
Number of scientists in my group previously or currently performing research at Department of Ophthalmology, Harvard Medical School: 38 |
Invited talks (in total: 92, whereof 32 international (underlined)):
MSD Ophthalmology National Meeting, Oslo, Norway, 2006 |
XXXVII Nordic Congress of Ophthalmology, Copenhagen, Denmark, 2006 |
The Norwegian Society of Ophthalmology, Oslo, Norway, 2006 |
Pfizer`s Supplementary Training Meeting, Oslo, Norway, 2007 |
Oslo University Innovation talk at the “Opening of the Idea Polyclinic, Ullevål” with press coverage, August 17, 2007 |
Invited Speaker, Oslo Ophthalmology Society, Oslo, Norway, 2007 |
Oslo and Akershus University College, Norway, 2007 |
Inven2 Innovation prize talk, Rikshospitalet, Oslo University Hospital Norway (the main auditorium with press coverage), November 21, 2008 |
Cornea Innovation, Soria Moria, Oslo, Norway, September 2, 2008 |
Cambridge Innovation Center, Cambridge, MA, October 16, 2008 |
Inven2 Innovation prize talk with status after one year, Rikshospitalet, Oslo University Hospital Norway, November 20, 2009 |
Kyoto Prefectural University of Medicine, Japan, December 2009 |
El Centro de Oftalmologia Barraquer, Barcelona, Spain, August, 2009 |
Transplant Services Foundation, Hospital Clínic i Provincial de Barcelona, Spain, August, 2009 |
Invited Speaker, BMI (Biomedical innovation AS), Oslo, Norway, August 25, 2009 |
Invited Speaker, NeoMed, Oslo, November, Norway, 2009 |
DnB Nor, Oslo, Norway, November 2009 |
DLA Piper, Oslo, Norway, November 2009 |
Invited Speaker, Sigma fondsforvaltning AS, Oslo, Norway, September 10, 2009 |
Oslo University Hospital, Ulleval, Oslo, Norway, October 17, 2009 |
Southern and Eastern Norway Regional Health Authority Board Meeting (talk on innovation), Drammen, Norway December 10, 2009 |
The Norwegian Stem Cell Meeting, Losby, Lørenskog, Norway, October 19, 2010 |
The 2nd Asia Cornea Society Biennial Scientific Meeting, Kyoto, Japan, December 2, 2010 |
SOE Lecturer, The Norwegian Society of Ophthalmologists, Soria Moria, Norway, November 2, 2012 |
Harvard Cornea Center of Excellence Scientific Retreat, The American Academy of Arts and Sciences, US, December 15, 2012 |
Thea Laboratories (invited talk for the administration) Seattle, Washington, US, May 6, 2014 |
Schepens Eye Research Institute, Massachusetts Eye and Ear, Department of Ophthalmology, Harvard Medical School, Boston, US, May 30, 2013 |
Wayne State University, Detroit, US, June 24, 2013 |
The Royal Society of Medicine, London, UK, October 19, 2013 |
Department of Plastic and Reconstructive Surgery, Oslo University Hospital, Oslo, Norway, February 28, 2014 |
Newcastle University, Newcastle, UK, June 3, 2014 |
The German Ophthalmological Society, Leipzig, September 27, Germany, 2014 |
2nd European Conference on Aniridia, September 19, Italy, 2014 |
COST Training School, Nottingham, September, UK, 2014 |
Kongsberg Vision Meeting, October 27, 2014 |
Oslo Vest Rotery Club, October 29, 2014 |
BI Norwegian Business School, Oslo, Norway, September 3, 2014 |
University of California, Berkeley (BI Innovation project), CA, US, October 17, 2014 |
Craniofacial development biology course, Department of Oral Biology, University of Oslo, March 16, 2015 |
Aniridia Norway, Hurdal, Akershus, Oslo, May 30 2015 |
Oslo University Hospital Research Seminar (October 19, 2015) |
Sundvolden Conference Center, Hønefoss, Norway (October 27, 2015) |
Oslo Conference Center, Oslo, Norway (November 12, 2015) |
Oslo University Hospital Seminar (December 7, 2015) |
Innovation at Oslo University Hospital: “Brukerutvalget” Oslo University Hospital, March 25, 2016 |
The rationale for establishing a joint test bed for Oslo University Hospital and Oslo Municipality, Board of Directors, Oslo University Hospital, April 28, 2016 |
Testbeds in the health sector, Innovation network for the Southern Eastern Norway Regional Health Authority, Oslo, Norway, April 13 |
The rationale for establishing a joint test bed for Oslo University Hospital and Oslo Municipality, Conference for Health and Medical Technology, Drammen, April 14, 2016 |
Innovation – the sky is the limit, Telemark Hosptial Trust, Farris bad, Larvik, Norway, May 31, 2016 |
Innovation in dentistry, Faculty of Dentistry, Quality Hotel Leangkollen, Asker, Norway, June 1, 2016 |
Innovation – Oslo Tech, Oslo Science Park, Oslo, Norway, June 2, 2016 |
Innovation in ocular stem cell therapy, Department of Ophthalmology, Drammen Hospital, June 2, 2016 |
The use of oral mucosal cells for treating corneal blindness - how can it be possible and what other options are there in 2016? The Harvard seminar, Faculty of Dentistry, University of Oslo, June 8, 2016 |
The rationale for the establishment of test beds for Oslo University Hospital and Oslo Municipality, Oslo University Hospital, Aker, June 15, 2016 |
Nordic Congress of Ophthalmology, Aarhus, Denmark 8-12 June |
Innovation strategy for medical students, University of Oslo, August 15, 2016 |
The rationale for a testbed for Oslo University Hospital and the Municipality of Oslo, European telemedicine conference, Oslo Spectrum, Norway, August 16, 2016 |
Innovation in the health sector from an economic perspective, Oslo University Hospital (two-days seminar for economics at the hospital), August 25, 2016 |
3rd Scientific European Aniridia Conference 27-28th August 2016, Duisburg, Germany |
Innovation seminar, Faculty of Dentistry, University of Oslo (both speaker and moderator), January 18, 2017 |
Limbal stem cell deficiency, Charles University, Prague, Czech Republic, January 19, 2017 |
Innovation in the future, Division of Head, Neck and Reconstructive Surgery, Oslo University Hospital (two-days seminar, Norefjell, Norway, March 3, 2017 |
Stem cells and innovation – What is possible in 2017? - Agder Eye Seminar [Agder Øyelegeforum], Lillesand, Norway, March 7, 2017 |
Craniofacial development biology course, Department of Oral Biology, University of Oslo, March 20, 2017 |
Stem cell therapy, National Centre for Optics, Vision and Eye Care, University College of Southeast Norway, Norway, March 31, 2017 |
Treatment of corneal blindness - Norwegian Institute for air research, Kjeller, Norway, April 6, 2017 |
Innovation – opportunities and pitfalls, National Centre for Optics, Vision and Eye Care, University College of Southeast Norway, Norway, June 2, 2017 |
Innovation, Novartis Nordic Meeting, Tallinn, August 23, 2017 |
Dry eye disease – an update, Novartis Nordic Meeting, Tallinn, August 23, 2017 |
Stem cell in ophthalmology, Novartis Nordic Meeting, Tallinn, August 23, 2017 |
Dry eye disease – upcoming treatment strategies, Novartis Nordic Meeting, Tallinn, August 24, 2017 |
Innovation at Oslo University Hospital, Monrad Krohn Auditorium, Oslo, Norway, October 11, 2017 |
Innovation at the Univeristy of Oslo, Faculty of Dentistry, Oslo, Norway, November 1, 2017 |
Opportunities in Innovation, Oslo University Hospital, Monrad Krohn Auditorium, November 3, 2017 |
Ophthalmology for general practitioners, Novartis, Grand Hotel, Oslo, Norway, November 17, 2017 |
Innovation in research, OsloMet (three-hours seminar for research leaders at the university), Pilestredet 46, 0167 Oslo, Norway, January 24, 2018 |
Innovation, OsloMet (invited talk at a one-day seminar for the entire administration, including Rector, at OsloMet), Bristol hotel, Kristian IVs gate 7, 0164 Oslo, Norway, January 31, 2018 |
Innovation, Stavanger University Hospital, February 6, 2018 |
Innovation - what, why and how, Clinic of Neurology, Oslo University Hospital, February 28, 2018 |
Innovation, OsloMetropolitan University, March 7, 2018 |
Experiences from the Norwegian Dry Eye Clinic, Norvartis Nordic Advisory Board, Stockholm, March 21, 2018 |
Dry Eye Disease/The Norwegian Dry Eye Clinic, Novartis Ophthlamic Days, Nyborg, Denmark, April 14, 2018, |
Research driven innovation, Kosmopol, Copenhagen, Denmark, April 15, 2018 |
Innovation and ophthalmology, Boston University, April 26, 2018 |
Future innovation at Stavanger University Hospital, Stavanger University Hospital (invited by the CEO of the hospital), May 22, 2018 |
Management of dry eye disease, Shire, Stockholm, May 30, 2018 |
Innovation inspirational seminar (IT - students about 200 participants), Oslo Metropolitan University, Oslo, August 14, 2018 |
Dry eye disease – an update, Thea Laboratoies and Iogen, Helsinki, Finland, August 17, 2018 |
Innovation - why, when, how, Thea Laboratoies and Iogen, Stockholm, Sweden, August 18, 2018 |
Dry eye disease - unmet needs, Elsemay Björn symposium, Tampere, Finland, August 20 |
Stem cells: possibilities for therapy in 2018 – Nordic Congress of Ophthalmology, Oslo, August 22, 2018 |
Is it possible to do research in private practise? – Nordic Congress of Ophthalmology, Oslo, August 24, 2018 |
Innovation inspirational seminar, Oslo Metropolitan University (students with various background - about 300 participants), Oslo, August 27, 2018 |
Other (in Chronological Order):
1998: Co-founder of “I Ragazzi”. This unit was responsible for writing MED NYTT, a booklet for medical students that was published monthly for many years, and organizing classical music concerts and film events at regular intervals for medical students at the Faculty of Medicine in Oslo, Norway |
Disclosure of Invention (6 submitted since 2006; all accepted by Inven2, the largest Technology Transfer Office in Norway) |
2007: The first stem cell transplantation in Scandinavia using ex vivo cultured limbal epithelial cells was performed at the Department of Ophthalmology, Oslo University Hospital. To my knowledge, this transplantation was the first worldwide to include storage of cultured limbal epithelial cells for 4 days prior to the operation. The transplantation was based on research that resulted in a double PhD thesis on eye bank storage of cultured cells for Sten Ræder and me |
2010: Co-founder of a biotech company based on my own inventions in collaboration with Medinnova AS, which is now named Inven2 |
2010–present: Reviewer for scientific journals, including Progress in Retinal and Eye Research (impact factor: 11.5 ×1), Nanomedicine (5-year impact factor: 7 ×5), Stem Cells (impact factor: 6 ×1), Scientific Reports (impact factor: 5.5 × 2), Stem Cell Research & Therapy (×1), PLOS ONE (×1), Ocular Surface (×1), IOVS (×2), Experimental Eye Research (×1), Acta Ophthalmologica (×2), Current Eye Research (×2), Journal of Materials Science (×2), Organogenesis (×1), and Scandinavian Journal of Optometry and Visual Science (×1) |
2011–present: Associate member of the National Center for Stem Cell Research in Norway |
2011–present: Classical music advisor for The Center for Studies of Holocaust and Religious Minorities, University of Oslo, Oslo, Norway |
2012: Co-founder of the first Dry Eye Clinic in Scandinavia. The research clinic has recently expanded nationally and internationally (Iceland) and received substantial funding for research from several sources, including the Norwegian Research Council, The Association for the Blind and Partially Sighted in Norway, a public hospital (Elverum, Norway), 8 pharmaceutical companies, and a private eye clinic in Iceland |
2011–present: Editorial board member for Medark, University of Oslo |
2012–present: Editorial board member for Oftalmolog, a Nordic journal of ophthalmology |
2012: Development of a software (A Dry Eye Management System, ADEMS) in collaboration with Sten Ræder to enable improved diagnostics of dry eye disease and analysis of data for quality assessment or research. The software has resulted in great interest from eye clinics both in Norway and abroad as well as from the pharmaceutical industry, resulting in substantial external funding to further develop the software |
2013–present: Member of the Scientific Committee of Aniridia Europe |
2013–present: External examiner for 4 master’s theses |
2013–present: Regular columnist for the Norwegian journal Alt om Syn (“Everything About Vision”). Circulation: up to 700,000, 4 times yearly |
2014–present: Member of Network of Excellence in Corneal Regeneration, an EU research network based on EU funding (European Cooperation in Science and Technology [COST] Actions) |
May 4, 2014: Moderator at ARVO (the world’s largest eye congress) |
September 19, 2014: Expert panel member at the 2nd European Conference on Anirida, Italy |
2014–present: Evaluator of 2 master’s thesis and one digital publication following a 3-month medical research program at the University of Oslo |
Effective August 2014: Appointed “Innovation Contact” for several departments at Oslo University Hospital by the Oslo University Hospital Director of Innovation. My main task is to explore the innovative potential of research in these departments |
2014: Invited author of several review articles in several journals, including Journal of Functional Biomaterials (×3), Ophthalmology and Therapy (×1), and Medical Hypothesis, Discovery & Innovation Ophthalmology Journal (×1) (several manuscripts are currently in preparation) |
Author of several popular scientific reports and commentaries, including “Iris,” “Technical Weekly Magazine,” “Everything about Vision” (several times), and in the Journal of the Norwegian Medical Association |
December 2014: Board Member of NORBRAIN (Norwegian Brain Initiative; 14 members, including Nobel Prize Laureate Edvard Moser) |
Effective 2014: Funding without time restrictions for 4 full-time scientific positions at Oslo University Hospital |
June 2014: Appointed Head of the Electron Microscopy Laboratory, Institute of Oral Biology, University of Oslo. The laboratory has 2.5 technicians. Since the last quarter of 2015, I have shared the position with Professor Linda Hildegard Bergersen |
Submitted January 2015: Partner in EU application related to Innovation |
January 9, 2015: Best grade “A” at the oral exam for the first-third of a master’s degree in management in collaboration with The Norwegian Business School; University of California, Berkeley; and Stanford University |
January 27, 2015: Interview on stem cells by Nature Biotechnology on regenerative medicine [Nature Biotechnology, 33 (3), March 2015] |
March 5, 2015: Best grade “A” for thesis for the first-third of a master’s degree in management in collaboration with The Norwegian Business School; University of California, Berkeley; and Stanford University. The head of the innovation program at The Norwegian Business School has included our thesis in the teaching material as an example of an outstanding thesis to inspire new classes |
March 6, 2015: Accepted for the Research Leadership Programme at the University of Oslo for 2015 |
March 6, 2015: Head of a Strategy Committee on the role of innovation contacts at Oslo University Hospital (appointed by the Oslo University Hospital Director of Innovation) |
April 20, 2015–present: Editorial board member of International Journal of Experimental Dental Science |
April 11, 2015: Invited as co-organizer of the Corneal Regenerative Medicine session at the Nordic Congress of Ophthalmology in Denmark in 2016, which included an invitation to appoint a keynote speaker |
May 2015: Invited to be Moderator at ARVO |
June 17, 2015: Assessed as Professor Competent at the Faculty of Medicine, University of Oslo, at the first attempt of such evaluation (CV submitted January 17, 2015, at the age of 38 years). The assessment report concludes: “He is an ideal clinician-scientist with large potential to make major contributions in translational medical research.” |
June 19, 2015: External examiner of one PhD thesis |
July 20, 2015: Invited by the organizers of the 2016 Nordic Congress of Ophthalmology in Denmark to give a talk entitled “How to fast track your research career?” based on recent academic progress |
August 28, 2015: Appointed as assessment committee member to select the best publication during the first 6 months of 2016 from the Division of Diagnostics and Intervention, Institute of Clinical Medicine, Faculty of Medicine, University of Oslo |
October 19, 2015: Co-organizer and co-chair for the Oslo University Research Seminar |
December 7, 2015: Member of the 3rd Aniridia Europe Conference Scientific Organizer Committee |
October 2015: Appointed member of the advisory/working group of the Director of Innovation of the Southern Eastern Norway Regional Health Authority |
October 2015: Appointed project leader for the test lab project in collaboration with Oslo University Hospital and the municipality of Oslo |
2016: The only employee of the University of Oslo Faculty of Dentistry nominated for the University of Oslo Innovation Prize |
2016: Abstract nominated by the organization committee of the European Society of Ophthalmology for best poster award (co-author contribution) |
May 2016: Invitation to serve as moderator for 3 corneal sessions (paper: 267 - Corneal Epithelium Health and Disease, poster: 144 - Corneal Regenerative Medicine, poster: 439 - Corneal refractive surgery II) at ARVO, Seattle, TX |
2016: Invited to serve as Lead Guest Editor for a Special Issue of Journal of Ophthalmology |
2016: Appointed member of the Innovation Advisory Board, Oslo University Hospital |
June 8, 2016: Moderator of 2016 Oslo Dental Science Forum, Oslo Congress Center, Oslo, Norway |
August 25, 2016: Appointed “Innovation Contact” (i.e., responsible for innovation) for the Clinic of Laboratory Medicine, Oslo University Hospital. The Clinic of Laboratory Medicine is the largest clinic at the Institute of Clinical Medicine, Oslo University Hospital |
2016 - 2017: Examination committee member, Faculty of Dentistry, University of Oslo (the work consists of planning, writing, and correction of exams) |
January 1, 2017: Appointed Editor-in-Chief for Oftalmolog |
February 24, 2017: Appointed Norway Ambassador for the Tear Film & Ocular Surface Society. Only one ambassador is appointed from each country |
March 25, 2017: Reviewer for Biotechnology and Biological Sciences Research Council (BBSRC), the lead funding agency for academic research and training in the biosciences at universities and institutes throughout the UK |
May 4, 2017: Granted EU funding: Horizon 2020—Research and Innovation Framework Programme. Project title: Functional Hybrid Coatings by Molecular Layer Deposition (consortium member) |
May 6, 2017: Member of the Novartis Global Ocular Surface Advisory Board |
May 2017: Appointed member of the organizing committee and scientific committee for the Nordic Congress of Ophthalmology 2018 in Oslo, Norway |
May 2017: Invitation to serve as moderator for the dry eye disease and the corneal regenerative medicine paper session at the Nordic Congress of Ophthalmology 2018 in Oslo, Norway |
May 7-11, 2017: Moderator for 2 scientific sessions (dry eye disease and corneal biomechanics) at ARVO, Baltimore, US |
June 2017, Co-founder of Velotrail AS (company devoted to innovations related to bike security—6 co-founders, including previous Oslo University Hospital Director of Innovation, Kari Kværner) |
September 2017 to February 2018: Leadership development program, Oslo University Hospital |
2017: Head of PhD Committee for Miriam Landfors’s PhD thesis entitled: “Regulatory nucleotide modifications in Sertoli cells and germ cells.” First opponent: Dr. Gabriella Ficz, Centre for Haemato-Oncology, Barts Cancer Institute, John Vane Science Centre, Charterhouse Square, London, UK. Second opponent: Ann-Karin Olsen; Department of Molecular Biology Division of Infection Control and Environmental Health, Norwegian Institute of Public Health, Oslo, Norway |
April, 2018: Appointed professor in innovation at Oslo Metropolitan University, Oslo, 2018 (the first and currently only professorship in innovation at Oslo Metropolitan University) |
April 30, 2018: Moderator for a paper session (Dry Eye Clinical) at ARVO, Honolulu, Hawaii |
May 2, 2018: Moderator for a poster session at ARVO (Dry Eye Clinical II), Honolulu, Hawaii |
August 9, 2018: Member of the evaluation committee for the Innovation Competition at Oslo Metropoltian University Hospital, resulting in the Oslo Metropoltian University Award of NOK 80,000. The other members were Kristin Sverdrup, Director of Research, Oslo Metropoltian University Hospital and Christian Bjerke, Director of Innovation for Simula Innovation (https://www.simula.no) |
August, 2018: Consultant, Mundipharma AS, Dicks vei 10B, 1366 Lysaker, Norway |
Patent Applications Submitted (6)
United Kingdom Patent Application No. WO/2008/131973: Transplant storage I. Submitted by Inven2 April 26, 2007 |
United Kingdom Patent Application No. WO/2008/131973: Transplant storage II. Submitted by Inven2 April 4, 2008. |
United Kingdom Patent Application No. 1020436.0: Instant transplatation of cells Submitted by Stavanger University Hospital. Submitted by Inven2 December 2, 2010. |
United Kingdom Patent Application. A novel storage method for cultured retinal pigment epithelial cells for transplantation. Submitted by Inven2 Februar 28, 2014. |
United Kingdom Patent Application. A novel storage method for mammalian cells, tissue and organs. Submitted by Inven2 Februar 28, 2014. |
United Kingdom Patent Application No. 1511482.0: Growth medium retinal pigment epithelial (RPE)-cells. Submitted by Inven2 Juni 30, 2015. |
References:
Torstein Lyberg, MD, PhD, previous Director of Research at Unit of Regenerative Medicine, Department of Medical Biochemistry, Oslo University Hospital and main supervisor for my PhD; e-mail UXTOLY@ous-hf.no |
Numerous other references and letters of recommendation (in total 23) can be given on request from all previous employers. |